Arcalyst 220 MG vials
Ended Awarded
- Contract number
- SPE2DB25FEQDN
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,140
Award facts
- Contract value 100% obligated
- $24,140.14 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $24,140.14 by the Defense Logistics Agency (DLA) on September 12, 2025, for the supply of Arcalyst 220 mg vials. The delivery order, which carries no set-aside designation, is expected to be completed by October 3, 2025, with performance occurring at the contractor's Park Ridge facility. This award represents a discrete transaction issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a comprehensive pharmaceutical supply agreement valued at $500 million and extending through November 2026.
The delivery order supports the DLA's mission to provide medical supplies and pharmaceuticals to Department of Defense healthcare facilities worldwide. Arcalyst (rilonacept) is a specialty biologic medication used in the treatment of certain inflammatory conditions, reflecting the contractor's established capability to supply branded pharmaceutical products alongside generic medications, biologics, and medical consumables. DMS Pharmaceutical Group's track record of consistent contract awards with the DLA, combined with its woman-owned small business status, positions it as a key supplier within the federal pharmaceutical supply chain for military health system support.
Quick answers
Who was awarded contract SPE2DB25FEQDN?
SPE2DB25FEQDN was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 12, 2025.
How much is contract SPE2DB25FEQDN worth?
The government has obligated $24,140 on SPE2DB25FEQDN.
Is contract SPE2DB25FEQDN an order under another contract?
Yes. SPE2DB25FEQDN is a delivery order under SPE2DB24D9113, an indefinite delivery contract.
Was contract SPE2DB25FEQDN competed?
The extent of competition for SPE2DB25FEQDN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award